Patient recruitment was stopped prematurely after randomizing 888 patients at the request of an independent data and safety monitoring board as a result of a highly significant difference in the incidence rates of the composite primary end-point between both groups.
← all excerpts
FAME 2 - The best initial strategy for patients with stable coronary artery disease: Do we have an answer at last?
1
—
—